Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD)
Кардиометаболические коморбидные заболевания и осложнения ожирения и хронической болезни почек (ХБП)
2024-04-02
SCID: 54.1/569rkuq7
Discuss with AI
cardiometabolic complicationschronic kidney disease modulationobesity-related chronic kidney diseasepathophysiologyweight reduction
Figures from the paper
Abstract (AI)
Obesity and chronic kidney disease are two ongoing progressive clinical pandemics of major public health and clinical care significance. Because of their growing prevalence, chronic indolent course and consequent complications both these conditions place significant burden on the health care delivery system especially in developed countries like the United States. Beyond the chance coexistence of both of these conditions in the same patient based on high prevalence it is now apparent that obesity is associated with and likely has a direct causal role in the onset, progression and severity of chronic kidney disease. The causes and underlying pathophysiology of this are myriad, complicated and multi-faceted. In this review, continuing the theme of this special edition of the journal on " The Cross roads between Endocrinology and Nephrology" we review the epidemiology of obesity related chronic kidney disease (ORCKD), and its various underlying causes and pathophysiology. In addition, we delve into the consequent comorbidities and complications associated with ORCKD with particular emphasis on the cardio metabolic consequences and then review the current body of evidence for available strategies for chronic kidney disease modulation in ORCKD as well as the potential unique role of weight reduction and management strategies in its improvement and risk reduction.
Key Findings
1
Obesity and chronic kidney disease are progressive, highly prevalent conditions that impose substantial burdens on healthcare systems, particularly in developed countries.
2
Obesity is associated with, and likely directly contributes to, the onset, progression, and severity of chronic kidney disease.
3
Obesity-related chronic kidney disease arises through multifaceted and complex underlying causes and pathophysiological mechanisms.
4
Obesity-related chronic kidney disease produces important cardiometabolic comorbidities and complications.
5
The review evaluates kidney disease–modifying strategies and emphasizes weight reduction and management as potentially important approaches for improving outcomes and reducing risk.
Research Object
obesity-related chronic kidney disease (ORCKD)
Research Subject
the epidemiology, causes, pathophysiology, cardiometabolic comorbidities and complications, and strategies for CKD modulation and weight management in ORCKD
Publication Details
Publication Date
2024-04-02
Journal
Publisher
ISSN
Cited by
35
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai7
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin2002
Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 20172020
Once-Weekly Semaglutide in Adults with Overweight or Obesity2021
Tirzepatide Once Weekly for the Treatment of Obesity2022
European Guidelines for Obesity Management in Adults2015
Pathophysiology of Human Visceral Obesity: An Update2013
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management2023